Refractive Recovery and COVID-19
Five refractive leaders discuss how the world has changed for them – and the profession – since the pandemic hit
Aleksandra Jones | | Interview
Sat around our virtual table are:
Arthur Cummings, Medical Director of the Wellington Eye Clinic in Dublin, Ireland, chair and moderator
Sheraz Daya, Medical Director and Chairman of Centre for Sight in London, UK
Ben LaHood, refractive, cataract and laser vision correction surgeon in private practice in Auckland, New Zealand
Maria Scott, Chief Medical Officer of Vision Innovation Partners, Founding Partner and Medical Director of Chesapeake Eye Care and Laser Center, and Chesapeake Eye Surgery Center, and Medical Director at TLC Laser Eye Center in Annapolis, USA
Denise Visco, ocular surgeon and Medical Director and Founder of Eyes of York in Pennsylvania, USA
What impact has COVID-19 had on your practice – and what did re-opening your practice look like?
Denise Visco: I work at a small (two-surgeon) practice. We are based in central Pennsylvania, USA, and we employ three supporting optometrists. We closed around March 16, but we were able to reopen on May 2. Although we are fully open at this point, our guidelines for seeing patients have definitely changed. Our goal was to try to get back up to 100 percent of the throughput we had prior to COVID-19, and we were able to reach that target around the end of June, but with very different processes in place.
Following the changing curve of COVID-19 cases and working out new safety guidelines has been a challenge for me as the main decision maker.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine